StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences accrued rebates and chargebacks liability (Balance Sheet, $M) ($M)

Form 10-Q / 10-K Accrued Liabilities & Critical Accounting Estimates

QuarterlyAnnual
Latest, FY2025
4,337
Period ended Dec 31, 2025
Change on a year earlier
+11.4%
3,892 in FY2024
History
13 years
Since FY2013
Sources
12
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccrued rebates and chargebacks liability (Balance Sheet, $M) ($M)Year on yearSource
FY2025Dec 31, 20254,337+11.4%Form 10-Q (filed 2026-08-06) ↗
FY2024Dec 31, 20243,892+2.4%Form 10-K (filed 2026-02-24) ↗
FY2023Dec 31, 20233,802+9.3%Form 10-K (filed 2025-02-28) ↗
FY2022Dec 31, 20223,479+7.2%Form 10-K (filed 2024-02-23) ↗
FY2021Dec 31, 20213,244-19.1%Form 10-K (filed 2023-02-22) ↗
FY2020Dec 31, 20204,012-2.3%Form 10-K (gild-20211231.htm, filed 2022-02-23) ↗
FY2019Dec 31, 20194,108-7.1%Form 10-K (gild-20201231.htm, filed 2021-02-25) ↗
FY2018Dec 31, 20184,420-84.0%Form 10-K (a2019form10-k.htm, filed 2020-02-25) ↗
FY2017Dec 31, 201727,576+387.5%Form 10-K (a2019form10-k.htm, filed 2020-02-25) ↗
FY2016Dec 31, 20165,657+12.6%Form 10-K (a2017form10-k.htm, filed 2018-02-27) ↗
FY2015Dec 31, 20155,025+98.1%Form 10-K (a2016form10-k.htm, filed 2017-02-27) ↗
FY2014Dec 31, 20142,536+117.3%Form 10-K (a2015form10-k.htm, filed 2016-02-24) ↗
FY2013Dec 31, 20131,167–Form 10-K (a2014form10-k.htm, filed 2015-02-25) ↗

Breakdown

What makes up accrued rebates and chargebacks liability (balance sheet, $m)

Cite this data

StockData. (2026). Gilead Sciences Accrued rebates and chargebacks liability (Balance Sheet, $M) ($M), annual FY2013–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/gtn_rebates_liab

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.